Pulse treatment of human vascular endothelial cells with high doses of tumor necrosis factor and interferon-gamma results in simultaneous synergistic and reversible effects on proliferation and morphology

International Journal of Cancer

Volumn 77, Issue 4, 1998, Pages 592-599

  Yilmaz, Aysim ^a   Bieler, Grégory ^a   Spertini, Olivier ^a   Lejeune, Ferdy J ^a   Rüegg, Curzio ^a,b  

^a University of Lausanne Medical Center   (Switzerland)

^b C/O ISREC   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

MELPHALAN; RECOMBINANT GAMMA INTERFERON; RECOMBINANT TUMOR NECROSIS FACTOR;

APOPTOSIS; ARTICLE; CANCER CHEMOTHERAPY; CANCER INHIBITION; CELL PROLIFERATION; CELL STRUCTURE; DRUG POTENTIATION; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; NEOVASCULARIZATION (PATHOLOGY); PRIORITY JOURNAL; TUMOR NECROSIS; TUMOR VASCULARIZATION; VASCULAR ENDOTHELIUM;

APOPTOSIS; CELL DIVISION; CELL LINE; DRUG SYNERGISM; ENDOTHELIUM, VASCULAR; HUMANS; INTERFERON TYPE II; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031876881     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19980812)77:4<592::AID-IJC20>3.0.CO;2-7     Document Type: Article

References (39)

1. AGGARWAL, B.B. and NATARAJAN, K., Tumor necrosis factors: developments during the last decade. Europ. Cytokine Netw., 7, 93-124 (1996).
2. BALKWILL, F.R., Tumour necrosis factor and cancer. Prog. Growth Factor Res., 4, 121-137 (1992).
3. BALKWILL, F.R., LEE, A., ALDAM, G., MOODIE, E., THOMAS, J.A., TAVERNIER, J. and FIERS, W., Human tumor xenografts treated with recombinant human tumor necrosis factor alone or in combination with interferons. Cancer Res., 46, 3990-3993 (1986).
4. BEG, A.A. and BALTIMORE, D., An essential role for NF-kappa-b in preventing tnf-alpha-induced cell death. Science, 274, 782-784 (1996).
5. BENJAMIN, L.E. and KESHET, E., Conditional switching of vascular-endothelial-growth-factor(VEGF) expression in tumors: induction of endothelial-cell shedding and regression of hemangioblastoma-like vessels by VEGF withdrawal. Proc. nat. Acad. Sci. (Wash.), 94, 8761-8766 (1997).
6. BERENBAUM, M.C., Criteria for analyzing interactions between biologically active agents. Advanc. Cancer Res., 35, 269-327 (1981).
7. BRETT, J., GERLACH, H., NAWROTH, P., STEINBERG, S., GODMAN, G. and STERN, D., Tumor necrosis factor/cachectin increases permeability of endothelial-cell monolayers by a mechanism involving regulatory G proteins. J. exp. Med., 169, 1977-1991 (1989).
8. CARREL, S., HARTMANN, F., SALVI, S., ALBRECHT, H., SCHREYER, M. and RIMOLDI, D., Expression of type-A and -B tumor-necrosis-factor(TNF) receptors on melanoma cells can be regulated by dbc-AMP and IFN gamma. Int. J. Cancer, 62, 76-83 (1995).
9. DE KOSSODO, S., MOORE, R., GSCHMEISSNER, S., EAST, N., UPTON, C. and BALKWILL, F.R., Changes in endogenous cytokines, adhesion molecules and platelets during cytokine-induced tumour necrosis. Brit. J. Cancer, 72, 1165-1172 (1995).
10. DELI, M.A., DESCAMPS, L., DEHOUCK, M.P., CECCHELLI, R., JOO, F., ABRAHAM, C.S. and TORPIER, G., Exposure of tumor necrosis factor-alpha to luminal membrane of bovine brain capillary endothelial cells co-cultured with astrocytes induces a delayed increase of permeability and cytoplasmic stress-fiber formation of actin. J. neurosci. Res., 41, 717-726 (1995).
11. DOUKAS, J. and POBER, J.S., IFN-gamma enhances endothelial activation induced by tumor necrosis factor but not IL-1. J. Immunol., 145, 1727-1733 (1990).
12. EGGERMONT, A.M., SCHRAFFORDT KOOPS, H. KLAUSNER, J.M., LIÉNARD, D., KROON, B.B., SCHLAG, P.M., BEN-ARI, G. and LEJEUNE, F.J., Isolation limb perfusion with tumor necrosis factor alpha and chemotherapy for advanced extremity soft-tissue sarcomas. Semin. Oncol., 24, 547-555 (1997).
13. FOLKMAN, J., Angiogenesis in cancer, vascular, rheumatoide and other diseases. Nature Med., 1, 27-31 (1995).
14. FRATER-SCHRODER, M., RISAU, W., HALLMANN, R., GAUTSCHI, P. and BOHLEN, P., Tumor necrosis factor type alpha, a potent inhibitor of endothelial-cell growth in vitro, is angiogenic in vivo. Proc. nat. Acad. Sci. (Wash.), 84, 5277-5281 (1987).
15. FRIESEL, R., KOMORIYA, A. and MACIAG, T., Inhibition of endothelial-cell proliferation by gamma-interferon. J. Cell Biol., 104, 689-696 (1987).
16. GOLDBLUM, S.E., DING, X. and CAMPBELL-WASHINGTON, J., TNF-alpha induces endothelial-cell F-actin depolymerization, new actin synthesis, and barrier dysfunction. Amer. J. Physiol., 264, C894-905 (1993).
17. JOHNSON, D.R. and POBER, J.S., HLA-class-I heavy-chain gene-promoter elements mediating synergy between tumor necrosis factor and interferons. Mol. cell. Biol., 14, 1322-1332 (1994).
18. LAHM, H., SCHNYDER, B., WYNIGER, J., BORBENYI, Z., YILMAZ, A., CAR, B.D., FISCHER, J.R., GIVEL, J.C. and RYFFEL, B., Growth inhibition of human colorectal-carcinoma cells by interleukin-4 and expression of functional interleukin-4 receptors. Int. J. Cancer, 59, 440-447 (1994).
19. LIÉNARD, D., EGGERMONT, A.M.M., SCHRAFFORDT KOOPS, H., KROON, B.B.R., ROSENKAIMER, F., AUTIER, P. and LEJEUNE, F.J., Isolated perfusion of the limb with high-dose tumor necrosis factor-alpha (TNF-alpha), interferon gamma (IFN-gamma) and melphalan for melanoma stage III. Results of a multi-center pilot study. Melanoma Res., 4, Suppl. 1, 21-26 (1994).
20. LIÉNARD, D., EWALENKO, P., DELMOTTE, J.-J., RENARD, N. and LEJEUNE, F.J., High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma. J. clin. Oncol., 10, 52-60 (1992).
21. LIZARD, G., DECKERT, V., DUBREZ, L., MOISANT, M., GAMBERT, P. and LAGROST, L., Induction of apoptosis in endothelial cells treated with cholesterol oxides. Amer. J. Pathol., 148, 1625-1638 (1996).
22. MALIK, S.T. and BALKWILL, F.R., Anti-proliferative and anti-tumor activity of TNF in vitro and in vivo. Immunology Series, 56, 239-268 (1992).
23. NAKAICHI, M., TAKEUCHI, A., SASAKI, N., SHITARA, N. and TAKAKURA, K., Anti-tumor activity of natural-type human tumor necrosis factor on experimental brain tumors in rats. J. vet. med. Sci., 58, 885-891 (1996).
24. OHMORI, Y. and HAMILTON, T.A., The interferon-stimulated response element and a kappa-B site mediate synergistic induction of murine IP-10-gene transcription by IFN-gamma and TNF-alpha. J. Immunol., 154, 5235-5244 (1995).
25. PANDITA, R., POCSIK, E. and AGGARWAL, B.B., Interferon-gamma induces cell-surface expression for both types of tumor-necrosis-factor receptors. FEBS Lett., 312, 87-90 (1992).
26. PATTERSON, C., PERRELLA, M.A., ENDEGE, W.O., YOSHIZUMI, M., LEE, M.E. and HABER, E., Down-regulation of vascular endothelial-growth-factor receptors by tumor necrosis factor-alpha in cultured human vascular endothelial cells. J. clin. Invest., 98, 490-496 (1996).
27. REGENASS, U., MULLER, M., CURSCHELLAS, E. and MATTER, A., Anti-tumor effects of tumor necrosis factor in combination with chemotherapeutic agents. Int. J. Cancer, 39, 266-273 (1987).
28. RENARD, N., LIÉNARD, D., LESPAGNARD, L., EGGERMONT, A., HEIMANN, R. and LEJEUNE, F., Early endothelium activation and polymorphonuclear cell invasion precede specific necrosis of human melanoma and sarcoma treated by intravascular high-dose tumor necrosis factor alpha (rTNFα). Int. J. Cancer, 57, 656-663 (1994).
29. RENARD, N., NOOIJEN, P.T.G.A., SCHALWIJK, L., DE WAAL, R., EGGERMONT, A.M.M., LIÉNARD, D., KROON, B.B.R., LEJEUNE, F.J. and RUITER, D.J., Von-Willenbrand-factor release and platelet aggregation in human melanoma after perfusion with TNFα. J. Pathol., 176, 279-287 (1995).
30. RUBIN, B.Y., SMITH, L.J., HELLERMANN, G.R., LUNN, R.M., RICHARDSON, N.K. and ANDERSON, S.L., Correlation between the anti-cellular and DNA fragmenting activities of tumor necrosis factor. Cancer Res., 48, 6006-6010 (1988).
31. RUSZCZAK, Z., DETMAR, M., IMCKE, E. and ORFANOS, C.E., Effects of rIFN alpha, beta, and gamma on the morphology, proliferation, and cell-surface antigen expression of human dermal microvascular endothelial cells in vitro. J. invest. Dermatol., 95, 693-699 (1990).
32. SATO, N., GOTO, T., HARANAKA, K., SATOMI, N., NARIUCHI, H., MANO-HIRANO, Y. and SAWASAKI, Y., Actions of tumor necrosis factor on cultured vascular endothelial cells: morphologic modulation, growth inhibition, and cytotoxicity. J. nat. Cancer list., 76, 1113-1121 (1986).
33. SCHWEIGERER, L., MALERSTEIN, B. and GOSPODAROWICZ, D., Tumor necrosis factor inhibits the proliferation of cultured capillary endothelial cells. Biochem. biophys. Res. Comm., 143, 997-1004 (1987).
34. SPERTINI, O., LUSCINSKAS, F.W., KANSAS, G.S., MUNRO, J.M., GRIFFIN, J.D., GIMBRONE, M., JR. and TEDDER, T.F., Leukocyte adhesion molecule-1 (LAM-1, L-selectin) interacts with an inducible endothelial-cell ligand to support leukocyte adhesion. J. Immunol., 147, 2565-2573 (1991).
35. STOLPEN, A.H., GUINAN, E.C., FIERS, W. and POBER, J.. Recombinant tumor necrosis factor and immune interferon act singly and in combination to reorganize human vascular endothelial-cell monolayer. Amer. J. Pathol., 123, 16-24 (1986).
36. VANANTWERP, D.J., MARTIN, S.J., KAFRI, T., GREEN, D.R. and VERMA, T.M., Suppression of TNF-alpha-induced apoptosis by NF-kappa-b. Science, 274, 787-789 (1996).
37. VERMES, I., HAANEN, C., STEFFENS-NAKKEN, H. and REUTELINGSPERGER, C., A novel assay for apoptosis. Flow-cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein-labelled annexin V. J. immunol. Meth., 184, 39-51 (1995).
38. WARE, C.F., VANARSDALE, S. and VANARSDALE, T.L., Apoptosis mediated by the TNF-related cytokine and receptor families. J. Cell. Biochem., 60, 47-55 (1996).
39. YAN, S.R., FUMAGALLI, L., DUSI, S. and BERTON, G., Tumor necrosis factor triggers redistribution to a Triton X-100-insoluble, cytoskeletal fraction of beta 2 integrins, NADPH oxidase components, tyrosine-phosphorylated proteins, and the protein tyrosine kinase p58fgr in human neutrophils adherent to fibrinogen. J. Leukocyte Biol., 58, 595-606 (1995).